What does CUSIP 71426V306 represent in this 13F holders report?

CUSIP 71426V306 is the security identifier for PTXTQ - PERNIX THERAPEUTICS HLDGS IN - COM NEW used to aggregate holder disclosures.

How many institutions held PTXTQ - PERNIX THERAPEUTICS HLDGS IN - COM NEW in Q4 2018?

20 institutional investors reported PTXTQ - PERNIX THERAPEUTICS HLDGS IN - COM NEW for Q4 2018. Use the holders table for investor-level position and value details.

PERNIX THERAPEUTICS HLDGS IN - COM NEW (PTXTQ)

CUSIP: 71426V306

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class: Equity / COM NEW
Total 13F shares: 2,224,110
Share change: -822,658
Total reported value: $933,420
Put/Call ratio: 65%
Price per share: $0.42
Number of holders: 20
Value change: -$810,300
Number of buys: 12
Number of sells: 10

Quarterly Holders Quick Answers

What is CUSIP 71426V306?
CUSIP 71426V306 identifies PTXTQ - PERNIX THERAPEUTICS HLDGS IN - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2019
Previous quarter: Q3 2018

Recent filing periods for CUSIP 71426V306:

Q1 2019 Q4 2018 Q3 2018 Q2 2018 Q1 2018 Q4 2017 Q3 2017 Q2 2017

Institutional Holders of PERNIX THERAPEUTICS HLDGS IN - COM NEW (PTXTQ) as of Q4 2018

As of 31 Dec 2018, PERNIX THERAPEUTICS HLDGS IN - COM NEW (PTXTQ) was held by 20 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,224,110 shares. The largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., Aisling Capital LLC, GEODE CAPITAL MANAGEMENT, LLC, Vanguard Group Inc, BARCLAYS PLC, MARSHALL FINANCIAL GROUP INC /ADV, CREDIT SUISSE AG/, Cetera Investment Advisers, and CITADEL ADVISORS LLC. This page lists 20 institutional shareholders reporting positions in this security for the Q4 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.